J b chemicals and pharmaceuticals Ltd has received a significant penalty order from tax authorities in Tamil Nadu, as disclosed in a regulatory filing under SEBI Listing Regulations. The pharmaceutical company received the order on March 18, 2026 at 7:23 pm from the State Tax Officer, Intelligence, Chennai.

Penalty Details and Nature of Order

The tax authority has imposed a penalty of ₹80.81 crore under Section 74 of the Goods and Service Tax Act, 2017. The order specifically addresses alleged violations related to tax liability differences between the company's tax returns and books of accounts.

Alleged Violations and Period Covered

The order alleges reversal of tax liability for differences identified between tax returns filed and the company's books of accounts. The violations pertain to the financial period from April 2019 to March 2020, indicating the penalty relates to historical tax compliance matters.

Company's Response and Expected Impact

J.B. Chemicals & Pharmaceuticals has outlined its strategy to challenge the penalty order through the appellate process. The company's assessment indicates confidence in achieving a favorable outcome at the appellate level.

The company has specifically stated that based on its assessment, it does not reasonably expect the order to have any material financial impact on its operations. This disclosure was made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, ensuring transparency with stakeholders regarding regulatory developments that could potentially affect the company's financial position.

J B Chemicals and Pharmaceuticals Limited has announced another significant change in its senior management structure, disclosing the resignation of Ms. Sushree Mishra as General Manager-Corporate Strategy, Communication and In-licensing, effective March 13, 2026. This marks the fourth senior executive departure within the same month, following the earlier resignations of three other key executives.

Latest Senior Management Departure

Ms. Sushree Mishra formally submitted her resignation on February 9, 2026, requesting her last working day to be March 15, 2026, subject to organizational requirements. The company disclosed her cessation from the position effective from closing of business hours on March 13, 2026.

Previous Senior Management Departures

This latest departure follows the resignation of three other senior executives earlier in March 2026, creating a significant transition period for the pharmaceutical company's leadership structure.

Resignation Details and Transition

In her resignation letter addressed to the management, Ms. Sushree Mishra expressed gratitude for the opportunities and support provided during her tenure at JB Pharma, describing it as a valuable and enriching experience. She committed to ensuring a smooth transition of her responsibilities during the notice period and wished the organization continued success.

Regulatory Compliance and Disclosure

The disclosure was made in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication referenced SEBI Master Circulars bearing reference numbers SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and September 9, 2015.

Sandeep Phadnis, Vice President – Secretarial & Company Secretary, signed the formal communication to BSE Limited on March 13, 2026, requesting the exchange to take the resignation on record. The company provided a copy of the resignation letter as supporting documentation for the regulatory filing.

Company Operations

J.B. Chemicals & Pharmaceuticals Limited continues its pharmaceutical operations while managing this significant transition in senior leadership positions. The company maintains its registered office in Ahmedabad, Gujarat, and corporate office in Mumbai, Maharashtra, operating under the tagline "Good People for Good Health."